Sfoglia per Rivista HAEMATOLOGICA
On the potential involvement of CD11d in co-stimulating the production of interferon-γ by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3.
2011-01-01 Costantini, C; Micheletti, A; Calzetti, F; Perbellini, O; Tamassia, N; Albanesi, C; Vermi, William; Cassatella, Ma
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY
2019-01-01 Malagola, Michele; Efficace, Fabio; Polverelli, Nicola; Cottone, Francesco; Abruzzese, Elisabetta; Iurlo, Alessandra; Bucelli, Cristina; Stagno, Fabio; Bonifacio, Massimiliano; D'Adda, Mariella; Lunghi, Monia; Crugnola, Monica; Lunghi, Francesca; Castagnetti, Fausto; Rosti, Gianantonio; Luisa Ferrari, Maria; Bergamaschi, Micaela; Binotto, Gianni; Sancetta, Rosaria; Rosaria Coppi, Maria; Giai, Valentina; Rege Cambrin, Giovanna; Romano, Atelda; Tiribelli, Mario; Russo, Sabina; Aprile, Lara; Pia Falcone, Antonietta; Rupoli, Serena; Russo Rossi, Antonella; Usala, Emilio; Martino, Bruno; Gandolfi, Lisa; Bernardi, Simona; Zanaglio, Camilla; Farina, Mirko; Baccarani, Michele; Russo, Domenico
Other targets for Imatinib therapy
2003-01-01 Martinelli, G; Piccaluga, Pp; Malagola, Michele; Soverini, S; Rondoni, M; Isidori, A; Giannini, B; Grafone, T; Ottavini, E; De Vivo, A; Bonifazi, F; Bosi, C; Bianchini, M; Terragna, C; Fiacchini, M; Ricci, P; Visani, G; Russo, Domenico; Bassi, S; Trabacchi, E; Rosti, G; Buonamici, S; Alberti, D; Baccarani, M.
Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin
1996-01-01 Michieli, M.; Damiani, D.; Michelutti, M.; Melli, C.; Ermacora, A.; Geromin, A.; Fanin, R.; Russo, Domenico; Baccarani, M.
Overexpression of mdr-related p170 glycoprotein in chronic myeloid leukemia
1994-01-01 Michelutti, A; Michieli, M; Damiani, D; Melli, C; Geromin, A; Russo, Domenico; Fanin, R; Baccarani, M.
P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study
2026-01-01 Mutti, S.; Cavalleri, A.; Sicuranza, A.; Leoni, A.; Trenta, F.; Garuffo, L.; Xhahysa, B.; Re, F.; Bocchia, M.; Farina, M.; Malagola, M.; Russo, D.; Bernardi, S.
P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1
2026-01-01 Cavalleri, A.; Mutti, S.; Sicuranza, A.; Pacelli, P.; Leoni, A.; Ielo, C.; Paolini, L.; Mangolini, V.; Miracapillo, T.; Turriziani, C.; Abruzzese, E.; Farina, M.; Radeghieri, A.; Malagola, M.; Breccia, M.; Bocchia, M.; Russo, D.; Bernardi, S.
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR
2026-01-01 Leoni, A.; Farina, M.; Borlenghi, E.; Garuffo, L.; Xhahysa, B.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Morello, E.; Avenoso, D.; Russo, D.; Malagola, M.; Bernardi, S.
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia
2026-01-01 Leoni, A.; Farina, M.; Bertoli, D.; Giupponi, C.; Borlenghi, E.; Xhahysa, B.; Garuffo, L.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Avenoso, D.; Russo, D.; Malagola, M.; Bresciani, R.; Biasiotto, G.; Bernardi, S.
P170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin a derivatives
1994-01-01 Michieli, M; Damiani, D; Michelutti, A; Melli, C; Russo, Domenico; Fanin, R; Baccarani, M.
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE
2015-01-01 Skert, C.; Turra, A.; Malagola, Michele; Perucca, Simone; Cancelli, V.; Daffini, R.; Ribolla, R.; Bergonzi, C.; Filì, C.; Pagani, C.; DI PALMA, Andrea; Cattina, F.; Russo, Domenico
Pharmacology treatment of chronic asthma.
1998-01-01 Grassi, Vittorio; M., Malerba; S., Cossi; Tantucci, Claudio
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years.
2008-01-01 Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R.
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)
1989-01-01 Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S.
Pilot study of combined therapy with interferon-alfa, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase
1999-01-01 Russo, Domenico; Marin, L.; Bertone, A.; Tiribelli, M.; Testoni, N.; Martinelli, Giovanna
Plasma cell P170 expression and response to treatment in multiple myeloma
1996-01-01 Patriarca, F.; Melli, C.; Damiani, D.; Michieli, M.; Fanin, R.; Russo, Domenico; Michelutti, A.; Cavo, M.; Baccarani, M.
Polarization dictates iron handling by inflammatory and alternatively activated macrophages.
2010-01-01 G., Corna; L., Campana; E., Pignatti; A., Castiglioni; E., Tagliafico; L., Bosurgi; A., Campanella; S., Brunelli; A. A., Manfredi; Apostoli, Pietro; L., Silvestri; C., Camaschella; P., Rovere Querini
Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection
2001-01-01 Pirovano, S; Signorini, L; Facchetti, F; Santoro, A; Albertin, A; Imberti, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| On the potential involvement of CD11d in co-stimulating the production of interferon-γ by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3. | 1-gen-2011 | Costantini, C; Micheletti, A; Calzetti, F; Perbellini, O; Tamassia, N; Albanesi, C; Vermi, William; Cassatella, Ma | |
| OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY | 1-gen-2019 | Malagola, Michele; Efficace, Fabio; Polverelli, Nicola; Cottone, Francesco; Abruzzese, Elisabetta; Iurlo, Alessandra; Bucelli, Cristina; Stagno, Fabio; Bonifacio, Massimiliano; D'Adda, Mariella; Lunghi, Monia; Crugnola, Monica; Lunghi, Francesca; Castagnetti, Fausto; Rosti, Gianantonio; Luisa Ferrari, Maria; Bergamaschi, Micaela; Binotto, Gianni; Sancetta, Rosaria; Rosaria Coppi, Maria; Giai, Valentina; Rege Cambrin, Giovanna; Romano, Atelda; Tiribelli, Mario; Russo, Sabina; Aprile, Lara; Pia Falcone, Antonietta; Rupoli, Serena; Russo Rossi, Antonella; Usala, Emilio; Martino, Bruno; Gandolfi, Lisa; Bernardi, Simona; Zanaglio, Camilla; Farina, Mirko; Baccarani, Michele; Russo, Domenico | |
| Other targets for Imatinib therapy | 1-gen-2003 | Martinelli, G; Piccaluga, Pp; Malagola, Michele; Soverini, S; Rondoni, M; Isidori, A; Giannini, B; Grafone, T; Ottavini, E; De Vivo, A; Bonifazi, F; Bosi, C; Bianchini, M; Terragna, C; Fiacchini, M; Ricci, P; Visani, G; Russo, Domenico; Bassi, S; Trabacchi, E; Rosti, G; Buonamici, S; Alberti, D; Baccarani, M. | |
| Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin | 1-gen-1996 | Michieli, M.; Damiani, D.; Michelutti, M.; Melli, C.; Ermacora, A.; Geromin, A.; Fanin, R.; Russo, Domenico; Baccarani, M. | |
| Overexpression of mdr-related p170 glycoprotein in chronic myeloid leukemia | 1-gen-1994 | Michelutti, A; Michieli, M; Damiani, D; Melli, C; Geromin, A; Russo, Domenico; Fanin, R; Baccarani, M. | |
| P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study | 1-gen-2026 | Mutti, S.; Cavalleri, A.; Sicuranza, A.; Leoni, A.; Trenta, F.; Garuffo, L.; Xhahysa, B.; Re, F.; Bocchia, M.; Farina, M.; Malagola, M.; Russo, D.; Bernardi, S. | |
| P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1 | 1-gen-2026 | Cavalleri, A.; Mutti, S.; Sicuranza, A.; Pacelli, P.; Leoni, A.; Ielo, C.; Paolini, L.; Mangolini, V.; Miracapillo, T.; Turriziani, C.; Abruzzese, E.; Farina, M.; Radeghieri, A.; Malagola, M.; Breccia, M.; Bocchia, M.; Russo, D.; Bernardi, S. | |
| P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR | 1-gen-2026 | Leoni, A.; Farina, M.; Borlenghi, E.; Garuffo, L.; Xhahysa, B.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Morello, E.; Avenoso, D.; Russo, D.; Malagola, M.; Bernardi, S. | |
| P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia | 1-gen-2026 | Leoni, A.; Farina, M.; Bertoli, D.; Giupponi, C.; Borlenghi, E.; Xhahysa, B.; Garuffo, L.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Avenoso, D.; Russo, D.; Malagola, M.; Bresciani, R.; Biasiotto, G.; Bernardi, S. | |
| P170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin a derivatives | 1-gen-1994 | Michieli, M; Damiani, D; Michelutti, A; Melli, C; Russo, Domenico; Fanin, R; Baccarani, M. | |
| PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE | 1-gen-2015 | Skert, C.; Turra, A.; Malagola, Michele; Perucca, Simone; Cancelli, V.; Daffini, R.; Ribolla, R.; Bergonzi, C.; Filì, C.; Pagani, C.; DI PALMA, Andrea; Cattina, F.; Russo, Domenico | |
| Pharmacology treatment of chronic asthma. | 1-gen-1998 | Grassi, Vittorio; M., Malerba; S., Cossi; Tantucci, Claudio | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years. | 1-gen-2008 | Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R. | |
| Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL) | 1-gen-1989 | Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S. | |
| Pilot study of combined therapy with interferon-alfa, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase | 1-gen-1999 | Russo, Domenico; Marin, L.; Bertone, A.; Tiribelli, M.; Testoni, N.; Martinelli, Giovanna | |
| Plasma cell P170 expression and response to treatment in multiple myeloma | 1-gen-1996 | Patriarca, F.; Melli, C.; Damiani, D.; Michieli, M.; Fanin, R.; Russo, Domenico; Michelutti, A.; Cavo, M.; Baccarani, M. | |
| Polarization dictates iron handling by inflammatory and alternatively activated macrophages. | 1-gen-2010 | G., Corna; L., Campana; E., Pignatti; A., Castiglioni; E., Tagliafico; L., Bosurgi; A., Campanella; S., Brunelli; A. A., Manfredi; Apostoli, Pietro; L., Silvestri; C., Camaschella; P., Rovere Querini | |
| Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection | 1-gen-2001 | Pirovano, S; Signorini, L; Facchetti, F; Santoro, A; Albertin, A; Imberti, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile